Helen Murray Free Dies at 98; Chemist Developed Diabetes Test
Helen Murray Free, a chemist who co-developed the revolutionary dip-and-read diabetes test that simplified diagnosis and inspired other similar testing, has died.
Read MorePosted by Melanie Hamilton-Basich | May 6, 2021 | Diabetes & Metabolic Diseases |
Helen Murray Free, a chemist who co-developed the revolutionary dip-and-read diabetes test that simplified diagnosis and inspired other similar testing, has died.
Read MorePosted by Laurie Bonner | Feb 1, 2021 | Covid 19, Miscellaneous |
WHO’s yearly essential diagnostics list offers recommended in vitro diagnostics that should be available at point-of-care and in laboratories in all countries to increase timely and life-saving diagnoses.
Read MorePosted by Melanie Hamilton-Basich | Dec 4, 2020 | Allergy & Autoimmune, Cardiovascular, Hematology & Serology, Research |
Myriad Genetics shared new data further demonstrating that Vectra testing and three additional biomarkers can help predict the risk of cardiovascular events in patients with rheumatoid arthritis.
Read MorePosted by Melanie Hamilton-Basich | Aug 8, 2020 | Diabetes & Metabolic Diseases |
The combined type 1 diabetes risk score approach incorporates genetics, clinical factors such as family history, and the count of islet autoantibodies.
Read MorePosted by Laurie Bonner | Jun 22, 2020 | Uncategorized |
KidneyIntelX can identify patients at the highest risk of progressive decline in kidney function in early stage diabetic kidney disease.
Read More